Binge Drinking and Risk of Breast Cancer: Results from the SUN ('Seguimiento Universidad de Navarra') Project.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
10 Mar 2020
Historique:
received: 08 02 2020
revised: 04 03 2020
accepted: 06 03 2020
entrez: 14 3 2020
pubmed: 14 3 2020
medline: 15 12 2020
Statut: epublish

Résumé

Alcohol intake is associated with the risk of breast cancer. Different patterns of alcohol-drinking may have different effects on breast cancer even when keeping constant the total amount of alcohol consumed. We aimed to assess the association between binge drinking and breast cancer risk. The SUN Project is a Spanish dynamic prospective cohort of university graduates initiated in 1999. In the 556-item lifestyle baseline questionnaire a validated food-frequency questionnaire was embedded. Participants completed biennial follow-up questionnaires. Cox regression models were used to estimate the hazard ratio (HR) for breast cancer associated with the exposure to binge drinking. A stratified analysis was performed according to menopausal status. We included 9577 women (mean age = 34 years, SD = 10 years), with a median follow-up of 11.8 years. Among 104,932 women-years of follow-up, we confirmed 88 incident cases of breast cancer. Women in the binge drinking group showed a higher risk of breast cancer (HR = 1.76; 95% CI: 1.03-2.99) compared to women in the non-binge drinking category. In the stratified analysis, a 2-fold higher risk for premenopausal breast cancer was associated with binge drinking habit (HR = 2.06; 95% CI: 1.11-3.82). This study adds new evidence on the association of binge drinking with breast cancer risk.

Identifiants

pubmed: 32164388
pii: nu12030731
doi: 10.3390/nu12030731
pmc: PMC7146187
pii:
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundación Universitaria de Navarra
ID : PIUNA2004-32
Organisme : European Regional Development Fund - Instituto de Salud Carlos III
ID : PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795

Références

Eur J Public Health. 2007 Dec;17(6):624-9
pubmed: 17442702
MMWR Morb Mortal Wkly Rep. 2020 Jan 17;69(2):30-34
pubmed: 31945030
Cancer Res. 2000 Oct 15;60(20):5635-9
pubmed: 11059753
MMWR Surveill Summ. 2012 Jun 8;61(4):1-162
pubmed: 22673000
JAMA Intern Med. 2015 Nov;175(11):1752-1760
pubmed: 26365989
Int J Cancer. 2018 Oct 15;143(8):1849-1857
pubmed: 29708591
Eur J Nutr. 2019 Oct;58(7):2875-2886
pubmed: 30284064
J Natl Cancer Inst. 2010 Sep 22;102(18):1422-31
pubmed: 20733117
Lancet. 1988 Dec 3;2(8623):1267-73
pubmed: 2904004
J Obes. 2013;2013:291546
pubmed: 24073332
Int J Cancer. 1989 Apr 15;43(4):631-6
pubmed: 2703271
Nutrients. 2018 Mar 31;10(4):
pubmed: 29614726
Public Health Nutr. 2005 Oct;8(7):920-7
pubmed: 16277809
Mutat Res. 2009 Mar 9;662(1-2):3-9
pubmed: 19084543
Alcohol Clin Exp Res. 2004 Jul;28(7):1084-90
pubmed: 15252295
Am J Prev Med. 2014 Mar;46(3 Suppl 1):S16-25
pubmed: 24512927
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
JAMA. 1998 Feb 18;279(7):535-40
pubmed: 9480365
J Natl Cancer Inst. 1995 Jun 21;87(12):923-9
pubmed: 7666482
JAMA. 2011 Nov 2;306(17):1884-90
pubmed: 22045766
Am J Epidemiol. 2017 Sep 1;186(5):541-549
pubmed: 28486582
Cancer Causes Control. 2019 Nov;30(11):1183-1200
pubmed: 31471762
Lancet. 2005 Feb 5-11;365(9458):519-30
pubmed: 15705462
IARC Monogr Eval Carcinog Risks Hum. 2010;96:3-1383
pubmed: 21735939
Am J Epidemiol. 2009 Aug 1;170(3):308-17
pubmed: 19541857
Br J Nutr. 2014 May 28;111(10):1871-80
pubmed: 24480368
Int J Epidemiol. 2000 Aug;29(4):637-44
pubmed: 10922339
Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1736-1744
pubmed: 28877889
Int J Cancer. 2015 Oct 15;137(8):1921-30
pubmed: 25677034
Clin Transl Oncol. 2017 Jul;19(7):799-825
pubmed: 28093701
Sci Transl Med. 2013 Jan 30;5(170):170ra14
pubmed: 23363978
Alcohol Res Health. 2007;30(1):42-3
pubmed: 17718400
J Clin Endocrinol Metab. 2008 Oct;93(10):3833-8
pubmed: 18628524
Alcohol Alcohol. 2020 Apr 16;55(3):246-253
pubmed: 32090238
Br J Cancer. 2015 Sep 29;113(7):1099-103
pubmed: 26335605

Auteurs

Rodrigo Sánchez-Bayona (R)

Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Department of Clinical Oncology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.

Alfredo Gea (A)

Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), 28029 Madrid, Spain.
IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.

Itziar Gardeazabal (I)

Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Department of Clinical Oncology, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.

Andrea Romanos-Nanclares (A)

Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.

Miguel Ángel Martínez-González (MÁ)

Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), 28029 Madrid, Spain.
IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Maira Bes-Rastrollo (M)

Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), 28029 Madrid, Spain.
IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.

Marta Santisteban (M)

Department of Clinical Oncology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.

Estefanía Toledo (E)

Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), 28029 Madrid, Spain.
IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH